FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of pharmaceuticals and medicine. First invention is a solid dispersion for treating type I diabetes, type II diabetes, impaired glucose tolerance, fasting blood glucose and hyperglycemia disorders, which contains polymer carrier and activator of gluconase HMS5552, isotopic-labelled analogues or pharmaceutically acceptable salts,
.
Group of inventions also relates to a composition, a tablet and a capsule comprising said solid dispersion, and use of said dispersions, compositions, tablets and capsules for preparing a drug for treating or preventing type I diabetes, type II diabetes, impaired glucose tolerance, fasting blood glucose and hyperglycemia.
EFFECT: group of inventions provides pH-dependent dissolution of the dispersion and dosage forms based thereon.
36 cl, 9 dwg, 14 tbl, 21 ex
Title |
Year |
Author |
Number |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2781638C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
|
RU2780377C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yungo
- Van, Gaosen
- Gao, Khuejshen
|
RU2772875C1 |
PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND, CONTAINING A GLUCOKINASE ACTIVATOR AND AN ALPHA-GLUCOSIDASE INHIBITOR, METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2775603C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND AN SGLT-2 INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2770043C1 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A DPP-IV INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2770775C1 |
COATED COMPOUND CONTAINING PHARMACEUTICAL AGENT |
2004 |
- Klokkers Karin
- Tsell'Ner Marion
- Rill'Mann Tomas
- Dauer Andreas
|
RU2372893C2 |
DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE |
2019 |
- Ryzhakova Evgeniya Nikolaevna
- Shilov Maksim Sergeevich
- Lavrentev Viktor Vyacheslavovich
|
RU2742745C1 |
GALENICAL PREPARATIONS OF ORGANIC COMPOUNDS |
2010 |
- Sabina Desse-Brete
- Shtefan Khirsh
|
RU2535090C2 |
SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS |
2008 |
- Li Der-Jan
- Shehn' Robert
- Chehn' Dzhen-Chi
- Chehn' Vinsent
|
RU2471480C2 |